ArticleAnnals of translational medicine2022

The use of Esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial.

Yanbing Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.